Tumor suppressor p53 regulates bile acid homeostasis via small heterodimer partner

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 30, 2011, Pages 12266-12270

  Kim, Dae Hwan ^a   Lee, Jae W ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; HETERODIMER; PROTEIN P53; PROTEIN SHP; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BILE ACID SYNTHESIS; CONTROLLED STUDY; DOWN REGULATION; GENE TARGETING; GENETIC TRANSCRIPTION; HOMEOSTASIS; LIPID ABSORPTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; BASE SEQUENCE; BILE ACIDS AND SALTS; CHOLESTEROL 7-ALPHA-HYDROXYLASE; DOXORUBICIN; ENHANCER ELEMENTS, GENETIC; FEMALE; GENE EXPRESSION; GENES, P53; HOMEOSTASIS; INTESTINAL ABSORPTION; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; STEROID 12-ALPHA-HYDROXYLASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79961041330     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1019678108     Document Type: Article

References (48)

1. Warburg O (1956) On the origin of cancer cells. Science 123:309-314.
2. Jones RG, Thompson CB (2009) Tumor suppressors and cell metabolism: A recipe for cancer growth. Genes Dev 23:537-548.
3. Vousden KH, Ryan KM (2009) p53 and metabolism. Nat Rev Cancer 9:691-700.
4. Olovnikov IA, Kravchenko JE, Chumakov PM (2009) Homeostatic functions of the p53 tumor suppressor: Regulation of energy metabolism and antioxidant defense. Semin Cancer Biol 19:32-41.
5. Gottlieb E, Vousden KH (2010) p53 regulation of metabolic pathways. Cold Spring Harb Perspect Biol 2:a001040.
6. Chanda D, Park JH, Choi HS (2008) Molecular basis of endocrine regulation by orphan nuclear receptor Small Heterodimer Partner. Endocr J 55:253-268. (Pubitemid 351670949)
7. Chiang JY (2009) Bile acids: Regulation of synthesis. J Lipid Res 50:1955-1966.
8. Hofmann AF (1999) The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med 159:2647-2658.
9. Perez MJ, Briz O (2009) Bile-acid-induced cell injury and protection. World J Gastroenterol 15:1677-1689.
10. Bernstein H, Bernstein C, Payne CM, Dvorakova K, Garewal H (2005) Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res 589:47-65. (Pubitemid 40094591)
11. Chiang JYL, Kimmel R, Weinberger C, Stroup D (2000) FXR responds to bile acids and represses cholesterol 7a-hydroxylase gene (CYP7a1) transcription. J Biol Chem 275:10918-10924. (Pubitemid 30212727)
12. Goodwin B, et al. (2000) A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6:517-526.
13. Holt JA, et al. (2003) Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev 17:1581-1591. (Pubitemid 36828786)
14. Inagaki T, et al. (2005) Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2:217-25.
15. Gupta S, Stravitz RT, Dent P, Hylemon PB (2001) Down-regulation of cholesterol 7alpha-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N-terminal kinase pathway. J Biol Chem 276:15816-15822.
16. Wang L, et al. (2002) Redundant pathways for negative feedback regulation of bile acid production. Dev Cell 2:721-731. (Pubitemid 34650069)
17. Yu C, Wang F, Jin C, Huang X, McKeehan WL (2005) Independent repression of bile acid synthesis and activation of c-Jun N-terminal kinase (JNK) by activated hepatocyte fibroblast growth factor receptor 4 (FGFR4) and bile acids. J Biol Chem 280:17707-17714. (Pubitemid 41389008)
18. Li T, Jahan A, Chiang JY (2006) Bile acids and cytokines inhibit the human cholesterol 7 alpha-hydroxylase gene via the JNK/c-jun pathway in human liver cells. Hepatology 43:1202-1210. (Pubitemid 43980098)
19. Stravitz RT, et al. (1996) Hepatocellular protein kinase C activation by bile acids: Implications for regulation of cholesterol 7 α-hydroxylase. Am J Physiol 271:G293-G303. (Pubitemid 26295137)
20. De Fabiani E, et al. (2001) The negative effects of bile acids and tumor necrosis factor-α on the transcription of cholesterol 7α-hydroxylase gene (CYP7A1) converge to hepatic nuclear factor-4: A novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors. J Biol Chem 276:30708-30716.
21. Feingold KR, Spady DK, Pollock AS, Moser AH, Grunfeld C (1996) Endotoxin TNF, and IL-1 decrease cholesterol 7 α-hydroxylase mRNA levels and activity. J Lipid Res 37:223-228. (Pubitemid 26078941)
22. Miyake JH, Wang SL, Davis RA (2000) Bile acid induction of cytokine expression by macrophages correlates with repression of hepatic cholesterol 7α-hydroxylase. J Biol Chem 275:21805-21808. (Pubitemid 30621747)
23. Lee J, et al. (2009) A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4. Proc Natl Acad Sci USA 106:8513-8518.
24. Kim DH, Lee J, Lee B, Lee JW (2009) ASCOM controls farnesoid X receptor transactivation through its associated histone H3 lysine 4 methyltransferase activity. Mol Endocrinol 23:1556-1562.
25. Donehower LA, et al. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215-221.
26. Tsai W-W, Nguyen TT, Shi Y, Barton MC (2008) p53-targeted LSD1 functions in repression of chromatin structure and transcription in vivo. Mol Cell Biol 28:5139-5146.
27. Miao J, et al. (2009) Bile acid signaling pathways increase stability of small heterodimer partner (SHP) by inhibiting ubiquitin-proteasomal degradation. Genes Dev 15:986-996.
28. Galla HJ, Theilen U, Hartmann W (1979) Transversal mobility in bilayer membrane vesicles: use of pyrene lecithin as optical probe. Chem Phys Lipids 23:239-251.
29. Song X, Kaimal R, Yan B, Deng R (2008) Liver receptor homolog 1 transcriptionally regulates human bile salt export pump expression. J Lipid Res 49:973-984.
30. Zhang Y, et al. (2008) Orphan receptor small heterodimer partner suppresses tumorigenesis by modulating cyclin D1 expression and cellular proliferation. Hepatology 48:289-298. (Pubitemid 351975553)
31. Yang F, et al. (2007) Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor. Cancer Res 67:863-867.
32. Kim I, et al. (2007) Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice. Carcinogenesis 28:940-946. (Pubitemid 47072176)
33. Maran RR, et al. (2009) Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development. J Pharmacol Exp Ther 328:469-477.
34. Modica S, Murzilli S, Salvatore L, Schmidt DR, Moschetta A (2008) Nuclear bile acid receptor FXR protects against intestinal tumorigenesis. Cancer Res 68:9589-9594.
35. Hussain SP, Schwank J, Staib F, Wang XW, Harris CC (2007) TP53 mutations and hepatocellular carcinoma: Insights into the etiology and pathogenesis of liver cancer. Oncogene 26:2166-2176. (Pubitemid 46536641)
36. Zaika AI, El-RifaiW(2006) The role of p53 protein family in gastrointestinal malignancies. Cell Death Differ 13:935-940.
37. Watanabe M, et al. (2004) Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest 113:1408-1418. (Pubitemid 39071696)
38. Watanabe M, et al. (2006) Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439:484-489. (Pubitemid 43152840)
39. Minamino T, et al. (2009) A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat Med 15:1082-1087.
40. Shih DQ, et al. (2001) Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes 50:2472-2480. (Pubitemid 33642764)
41. Crestani M, Sadeghpour A, Stroup D, Galli G, Chiang JY (1998) Transcriptional activation of the cholesterol 7alpha-hydroxylase gene (CYP7A) by nuclear hormone receptors. J Lipid Res 39:2192-2200. (Pubitemid 28523125)
42. Lu TT, et al. (2000) Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 6:507-515.
43. Lee YK, Parker KL, Choi HS, Moore DD (1999) Activation of the promoter of the orphan receptor SHP by orphan receptors that bind DNA as monomers. J Biol Chem 274:20869-20873.
44. Lee J, et al. (2010) A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition. J Biol Chem 285:12604-12611.
45. Yahagi N, et al. (2004) p53 involvement in the pathogenesis of fatty liver disease. J Biol Chem 279:20571-20575. (Pubitemid 38656450)
46. Sinal CJ, et al. (2000) Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 101:731-744.
47. Chen WD (2010) Farnesoid X receptor alleviates age-related proliferation defects in regenerating mouse livers by activating forkhead box m1b transcription. Hepatology 51:953-962.
48. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M (2000) Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843-852.